A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS. (Q31121891)

29 June 2017

A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS. (English)

1 reference

29 June 2017

0 references

0 references

1 reference

L Mu

1

1 reference

PubMed ID

12490371

29 June 2017

S S Feng

series ordinal

2

1 reference

PubMed ID

12490371

29 June 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

Journal of Controlled Release

29 June 2017

1 reference

29 June 2017

86

1 reference

29 June 2017

33-48

1 reference

29 June 2017

1

1 reference

Improving protein delivery from microparticles using blends of poly(DL lactide co-glycolide) and poly(ethylene oxide)-poly(propylene oxide) copolymers

29 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900320-6

7 January 2021

Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) microcapsules: problems associated with preparative techniques and release properties

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900320-6

7 January 2021

Disposition kinetics and oral bioavailability of vincamine-loaded polyalkyl cyanoacrylate nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900320-6

7 January 2021

Retention and clearance of 0.9-micron particles inhaled by hamsters during rest or exercise.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900320-6

7 January 2021

Effect of nanoparticles on transdermal drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900320-6

7 January 2021

Nanocapsules: A new type of lysosomotropic carrier

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900320-6

7 January 2021

Influence of polybutylcyanoacrylate nanoparticles and liposomes on the efficacy and toxicity of the anticancer drug mitoxantrone in murine tumour models

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900320-6

7 January 2021

Enhanced cytotoxicity of doxorubicin encapsulated in polyisohexylcyanoacrylate nanospheres against multidrug-resistant tumour cells in culture.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900320-6

7 January 2021

Tissue distribution of doxorubicin associated with polyisohexylcyanoacrylate nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900320-6

7 January 2021

The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900320-6

7 January 2021

Revisiting PLA/PLGA microspheres: an analysis of their potential in parenteral vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900320-6

7 January 2021

Paclitaxel and its formulations

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900320-6

7 January 2021

Effects of cyclosporin and cremophor on working rat heart and incidence of myocardial lipid peroxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900320-6

7 January 2021

Pharmacology and toxicology of Cremophor EL diluent

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900320-6

7 January 2021

Is Cremophor EL, solvent for paclitaxel, cytotoxic?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900320-6

7 January 2021

Measurement of cremophor EL following taxol: plasma levels sufficient to reverse drug exclusion mediated by the multidrug-resistant phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900320-6

7 January 2021

Acute effects of cyclosporin and cremophor EL on endothelial function and vascular smooth muscle in the isolated rat heart

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900320-6

7 January 2021

Interaction of cremophor EL with human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900320-6

7 January 2021

Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol).

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900320-6

7 January 2021

The preparation of sub-200 nm poly(lactide-co-glycolide) microspheres for site-specific drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900320-6

7 January 2021

A New Long-Acting Injectable Microcapsule System for the Administration of Progesterone

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900320-6

7 January 2021

Preparation and characterization of poly(lactic-co-glycolic acid) microspheres for targeted delivery of a novel anticancer agent, taxol

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900320-6

7 January 2021

Preparation and characterization of sterile and freeze-dried sub-200 nm nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900320-6

7 January 2021

Preparation of poly(DL-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900320-6

7 January 2021

Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900320-6

7 January 2021

10.1016/S0168-3659(02)00320-6

Identifiers

DOI

1 reference

29 June 2017

0 references

1 reference

PubMed ID

12490371